Dye-enhanced selective photothermal laser-tissue interaction and photodynamic therapy in combination with immunoadjuvant for cancer treatment

Wei R. Chen; Kenneth Eugene Bartels D.V.M.; Jinghai Sun; Hong Liu; Robert E. Nordquist; Mladen Korbelik

doi:10.1117/12.546093

8 December 2003 Dye-enhanced selective photothermal laser-tissue interaction and photodynamic therapy in combination with immunoadjuvant for cancer treatment

Wei R. Chen, Kenneth Eugene Bartels D.V.M., Jinghai Sun, Hong Liu, Robert E. Nordquist, Mladen Korbelik

Author Affiliations +

Proceedings Volume 5254, Third International Conference on Photonics and Imaging in Biology and Medicine; (2003) https://doi.org/10.1117/12.546093
Event: Third International Conference on Photonics and Imaging in Biology and Medicine, 2003, Wuhan, China

Abstract

Immunoadjuvants have been used to stimulate host immune responses. However, immunoadjuvants alone have not been very successful in treating metastatic tumors. Following the principle of combined therapy in AIDS treatment and in combination chemotherapy, immunoadjuvants have been used in conjunction with other treatment modalities. The current study is an attempt to use both selective photothermal and selective photochemical interactions to accompany a new immunoadjuvant in the treatment of metastatic tumors. The immunoadjuvant, glycated chitosan (GC), has been shown in the previous studies to be effective in inducing immune responses when combined with the treatment of laser irradiation after the intratumoral injection of indocyanine green solution. When glycated chitosan was used with photodynamic therapy (PDT), the treatment effect was significantly increased. Specifically, when glycated chitosan was injected peritumorally after Photofrin-based PDT treatment of EMT6 mammary sarcoma in mice, the tumor-free rate of the treated mice was increased from 38% to 75% using 1.5% GC solution. In mTHPC-based PDT treatment of Line-1 lung adenocarcinoma in mice, the tumor-free rates of treated mice reached 38% while PDT alone did not result in any tumor free mouse. The combination of the immunoadjuvant and selective photophysical interaction may become an effective method to treat tumors with an induced anti-tumor immunity.

Citation Download Citation

Wei R. Chen, Kenneth Eugene Bartels D.V.M., Jinghai Sun, Hong Liu, Robert E. Nordquist, and Mladen Korbelik "Dye-enhanced selective photothermal laser-tissue interaction and photodynamic therapy in combination with immunoadjuvant for cancer treatment", Proc. SPIE 5254, Third International Conference on Photonics and Imaging in Biology and Medicine, (8 December 2003); https://doi.org/10.1117/12.546093

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available